Butyrate Protects Barrier Integrity and Suppresses Immune Activation in a Caco-2/PBMC Co-Culture Model While HDAC Inhibition Mimics Butyrate in Restoring Cytokine-Induced Barrier Disruption
Low-grade inflammation and barrier disruption are increasingly acknowledged for their association with non-communicable diseases (NCDs). Short chain fatty acids (SCFAs), especially butyrate, could be a potential treatment because of their combined anti-inflammatory and barrier- protective capacities...
Main Authors: | Sandra G. P. J. Korsten, Herman Vromans, Johan Garssen, Linette E. M. Willemsen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-06-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/15/12/2760 |
Similar Items
-
The Potential Role of Probiotics, Especially Butyrate Producers, in the Management of Gastrointestinal Mucositis Induced by Oncologic Chemo-Radiotherapy
by: Massimiliano Cazzaniga, et al.
Published: (2024-02-01) -
Butyrate Prevents Induction of CXCL10 and Non-Canonical IRF9 Expression by Activated Human Intestinal Epithelial Cells via HDAC Inhibition
by: Sandra G. P. J. Korsten, et al.
Published: (2022-04-01) -
The Effects of Sodium Butyrate, Coated Sodium Butyrate, and Butyric Acid Glycerides on Nutrient Digestibility, Gastrointestinal Function, and Fecal Microbiota in Turkeys
by: Zbigniew Makowski, et al.
Published: (2022-07-01) -
Butyrate Glycerides Protect against Intestinal Inflammation and Barrier Dysfunction in Mice
by: Haidong Wang, et al.
Published: (2022-09-01) -
The specificity of ten non-digestible carbohydrates to enhance butyrate-producing bacteria and butyrate production in vitro fermentation
by: Jingjing Xu, et al.
Published: (2023-11-01)